COPD Exacerbations and Increased Cardiovascular Risk

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Nitin Seam, MD, assistant professor of medicine at George Washington University, talks with Anant Patel, MBBS, MRC clinical research fellow at the Center for Respiratory Medicine, University College London, and Mark Dransfield, MD, associate professor of medicine at UAB School of Medicine and medical director of the UAB Lung Health Center, about a new study of the link between acute exacerbations of COPD and cardiovascular risk.

To listen to this podcast, click here.
Related Articles
Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients’ treatment preferences when chronic disease is present.
While statins are among the most commonly prescribed medications for the prevention of cardiovascular disease, a recent study suggests that the use of statins may increase a patient’s risk of developing cataracts.
The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.
Since no medications or surgical procedures are available to treat cardiovascular calcification, clinicians generally recommend lifestyle changes.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$